Goski is now pursuing claims under the Americans with Disabilities Act, the Family and Medical Leave Act, and the Age ...
The two properties strengthen the Company's presence in Illinois, where it currently owns and manages three other properties.
In early January 2026, Abbott Laboratories unveiled Libre Assist, an AI-powered feature within its Libre app that helps U.S.
Buy Abbott: defensive compounder with recurring cash flow. Libre diabetes devices drive growth; 2025 guidance reaffirmed.
Zacks Investment Research on MSN
Here is what to know beyond why Abbott Laboratories (ABT) is a trending stock
Abbott (ABT) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...
Abbott Laboratories must pay $495 million in damages in the case of a girl who developed a serious gastrointestinal disease as a premature infant after consuming Abbott formula, a Missouri jury ...
Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.
Abbott's (NYSE: ABT) newest sensor-based glucose technology, the FreeStyle Libre 3 Plus* sensor, is now publicly funded in ...
Get the live share price of Abbott Laboratories (ABT), including intraday charts, historical performance, key financials, and market updates. Track the latest US stock market activity.
The two properties strengthen the Company's presence in Illinois, where it currently owns and manages three other properties.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback